POLARCOOL AB
PolarCool AB (publ), a medical device company, develops, markets, and sells products for sports medicine. The company offers PolarCap System, a portable cooling device for the treatment of concussive and sub-concussive brain injury. It serves teams, organizations, and athletes. PolarCool AB (publ) was incorporated in 2017 and is based in Lund, Sweden.
POLARCOOL AB (98H) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, POLARCOOL AB (98H) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
POLARCOOL AB - Net Assets Trend (None–None)
This chart illustrates how POLARCOOL AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for POLARCOOL AB (None–None)
The table below shows the annual net assets of POLARCOOL AB from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to POLARCOOL AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
POLARCOOL AB Competitors by Market Cap
The table below lists competitors of POLARCOOL AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Daelim Trading
KO:006570
|
$3.50 Million |
|
BIRD RIVER RES. INC.
F:1Q1A
|
$3.50 Million |
|
Duoback Co. Ltd
KQ:073190
|
$3.50 Million |
|
Apimeds Pharmaceuticals US, Inc.
NYSE MKT:APUS
|
$3.50 Million |
|
Excel Realty N Infra Limited
NSE:EXCEL
|
$3.49 Million |
|
Energy Development Company Limited
NSE:ENERGYDEV
|
$3.49 Million |
|
Ipevo Corporation
TWO:6858
|
$3.49 Million |
|
MRO-TEK Realty Limited
NSE:MRO-TEK
|
$3.49 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in POLARCOOL AB's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares POLARCOOL AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently POLARCOOL AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares POLARCOOL AB's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| POLARCOOL AB (98H) | €- | N/A | N/A | $3.49 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.30 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $42.41 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.72 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $620.14 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.29 Million |